Merrimack Pharmaceuticals Inc Stock Nasdaq
Equities
US5903281005
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net cash position 2022 | 19.44M | Net cash position 2023 | 18.88M | EV / Sales 2023 | - |
P/E ratio 2022 |
-100
x | P/E ratio 2023 |
-162
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.79% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Director/Board Member | 45 | 19-09-18 | |
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |